Could Coronavirus Disease 2019 (COVID-19) Render Natural Immunity to Re-infections? A Spotlight on the Therapeutic Pipeline. Front Immunol 2020;11:1294
Date
06/26/2020Pubmed ID
32582221Pubmed Central ID
PMC7290157DOI
10.3389/fimmu.2020.01294Scopus ID
2-s2.0-85086783429 12 CitationsAuthor List
Abid MA, Nunley L, Abid MBAuthor
Muhammad Bilal Abid MD Assistant Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antibody-Dependent EnhancementAntiviral Agents
Betacoronavirus
Coronavirus Infections
Drug Repositioning
Humans
Immunity, Innate
Immunization, Passive
Pandemics
Pneumonia, Viral
